Literature DB >> 20435784

The reliability and practicality of the Arkansas method assay of isoniazid adherence.

Katharine E Schmitz1, Melbourne F Hovell, Charlene A Wong, Norma J Kelley, Donata Nilsen, Elaine J Blumberg, Linda L Hill, Carol L Sipan, Bo Kolody, Dale A Chatfield.   

Abstract

The Arkansas method (AM) for isoniazid (INH) metabolite detection is a relatively inexpensive, simple, objective measure of adherence. The purpose of the study was to explore whether variations in urine sample handling and storage will produce accurate assay outcomes. Participants were a convenience sample of 28 adults and adolescents prescribed INH for latent tuberculosis infection. Participants provided one sample to test effects of the following: mixing processes; durations at room temperature, in a refrigerator, or frozen; and effects of freeze/thaw cycles on AM outcomes. No manipulations had a discernible impact on outcomes with concordant positive rates from 85% to 100%. Concordance rates of manipulated samples did not appear to differ from rates of norm samples. Results suggest that urine samples can withstand a variety of manipulations in both handling and storage without affecting the accuracy of AM assay results. These findings have important implications for providers of treatment and researchers and provide the impetus for both to examine the potential of using the AM of INH metabolite testing as a measure of medication adherence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435784      PMCID: PMC3510760          DOI: 10.1177/1054773810363473

Source DB:  PubMed          Journal:  Clin Nurs Res        ISSN: 1054-7738            Impact factor:   2.075


  22 in total

1.  Urine color testing and isoniazid monitoring.

Authors:  Graham F Cope; Ruth Whitfield
Journal:  Chest       Date:  2003-12       Impact factor: 9.410

2.  Treatment of tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2003-06-20

3.  Preventive effects of isoniazid in the treatment of primary tuberculosis in children.

Authors:  F W MOUNT; S H FEREBEE
Journal:  N Engl J Med       Date:  1961-10-12       Impact factor: 91.245

4.  Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection.

Authors:  Tal Eidlitz-Markus; Avraham Zeharia; Gerald Baum; Marc Mimouni; Jacob Amir
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

5.  Patient knows best: blinded assessment of nonadherence with antituberculous therapy by physicians, nurses, and patients compared with urine drug levels.

Authors:  C R Macintyre; K Goebel; G V Brown
Journal:  Prev Med       Date:  2005-01       Impact factor: 4.018

6.  Adherence to tuberculosis preventive therapy among Latino immigrants.

Authors:  R L Ailinger; M R Dear
Journal:  Public Health Nurs       Date:  1998-02       Impact factor: 1.462

7.  Low level of compliance with tuberculosis treatment in children: monitoring by urine tests.

Authors:  Ayşe Palanduz; Derya Gültekin; Ela Erdem; Nimet Kayaalp
Journal:  Ann Trop Paediatr       Date:  2003-03

Review 8.  When tuberculosis treatment fails. A social behavioral account of patient adherence.

Authors:  E Sumartojo
Journal:  Am Rev Respir Dis       Date:  1993-05

9.  A tuberculin screening and isoniazid preventive therapy program in an inner-city population.

Authors:  N N Bock; B S Metzger; J R Tapia; H M Blumberg
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

10.  Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis.

Authors: 
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

View more
  2 in total

1.  Potential to Use Fingerprints for Monitoring Therapeutic Levels of Isoniazid and Treatment Adherence.

Authors:  Mahado Ismail; Catia Costa; Katherine Longman; Mark A Chambers; Sarah Menzies; Melanie J Bailey
Journal:  ACS Omega       Date:  2022-04-21

2.  Point-of-care urine tests for smoking status and isoniazid treatment monitoring in adult patients.

Authors:  Ioana Nicolau; Lulu Tian; Dick Menzies; Gaston Ostiguy; Madhukar Pai
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.